Date Released
28 May, 2021
body.kc-css-system .kc-css-2759363{margin-top: 30px;padding-top: 38px;}body.kc-css-system .kc-css-127615 .section-title h2,body.kc-css-system .kc-css-127615 .title_tx h2{font-size: 1.4em;padding-top: 27px;}body.kc-css-system .kc-css-127615 .section-title h2 span,body.kc-css-system .kc-css-127615 .title_tx h2 span,body.kc-css-system .kc-css-127615 .em-icon i{color: #973333;}body.kc-css-system .kc-css-3115636 .divider_inner{border-color: #fcb100;border-style: solid;}body.kc-css-system .kc-css-652969.kc_title,body.kc-css-system .kc-css-652969 .kc_title,body.kc-css-system .kc-css-652969 .kc_title a.kc_title_link{font-size: 1.2em;}body.kc-css-system .kc-css-1770419 .divider_inner{border-color: #fcb100;border-style: solid;}body.kc-css-system .kc-css-2859608{background: rgba(245, 253, 255, 0.37);margin-top: 24px;padding-top: 24px;}body.kc-css-system .kc-css-3960192.kc_title,body.kc-css-system .kc-css-3960192 .kc_title,body.kc-css-system .kc-css-3960192 .kc_title a.kc_title_link{padding-top: 0px;margin-top: -40px;}
Planning for Fall Respiratory Illnesses
Recommendations for Industry
Planning for Fall Respiratory Illnesses
With vaccinations continuing to increase and cases continuing to decrease, TAG is seeing all indications pointing to a relatively quiet summer as far as COVID-19 is concerned. But while you enjoy that bit of reprieve, know that the fall will undoubtedly bring a return to the usual respiratory illnesses – i.e., colds and flu.
What will be different this year from pre-COVID years is that the “usual” respiratory illness symptoms will need to be taken more seriously as many of the symptoms (e.g., fever, cough, chills) are similar to those of COVID-19, and are highly transmissible regardless of the person’s viral condition. Thus making a focus on respiratory hygiene of continued importance for businesses.
On the plus side, the pandemic has provided us all with more awareness of the risks and impacts of respiratory illnesses – and we have more strategies to fight against their transmission and the increased employee absences and business impacts.
As we move through the summer, TAG will continue to keep an eye on the public health situation and advise readers accordingly. We also are developing fall/respiratory illness strategies to assist businesses, restructuring our Hierarchy of Controls for relevance, and will be helping businesses convert or develop programs to be prepared for, and reduce the impact of, fall and winter illnesses.
Keep an eye on this space and give us a call with any questions or pre-planning assistance.
In Case You Missed It
- In Wednesday’s Recommendations for Industry, we discussed this week’s COVID-19 Risk Matrix as well as a perspective on CDC’s travel recommendations. Read more here.
- The CDC has provided new recommendations for domestic travel for vaccinated and unvaccinated individuals in the U.S. including recommending that unvaccinated individuals should not travel until they are fully vaccinated. However, if unvaccinated individuals do want to travel, they should follow CDC’s recommendations for unvaccinated people.

- NPR reports that in 25 states, more than 50% of all adults are fully vaccinated! The majority are in the Northeastern states of Maine, Vermont, Massachusetts, Rhode Island, and Connecticut.
- In South Africa, testing of wastewater is helping to identify the spread of COVID-19.
- Moderna is applying for FDA approval of its COVID-19 vaccine for 12-17 year olds.
- In Monday’s Recommendations for Industry, we discussed the importance of maintaining robust hygiene practices even while reducing other COVID-19 protections. Read more here.
- At this time, OSHA tells employers to follow CDC’s mask guidance. Both National Law Review & JD Supra break down what this means.
- Hospitals in Japan continue to struggle with the COVID-19 outbreak. However, the International Olympic Committee has said that Tokyo Summer Games will continue
- CNN discusses the “black fungus” infections that are also an epidemic in India at this time.
- A new study estimates that COVID-19 may have killed 20% more individuals than currently reported, specifically, “[f]or every 100 deaths attributed to COVID-19, another 20 deaths were ascribed to other causes.”
- CIDRAP reports, “at the G20 Global Health Summit […] world leaders and drug companies announced major commitments to boost the supply of COVID vaccine for low- and middle-income countries, but stopped short of endorsing a full waiver of vaccine patent rights.”
- Food Safety & Public Health: